624 related articles for article (PubMed ID: 9759903)
1. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
[TBL] [Abstract][Full Text] [Related]
3. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
Krakowski ML; Owens T
Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
[TBL] [Abstract][Full Text] [Related]
4. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
5. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis.
Bauer J; Huitinga I; Zhao W; Lassmann H; Hickey WF; Dijkstra CD
Glia; 1995 Dec; 15(4):437-46. PubMed ID: 8926037
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
[TBL] [Abstract][Full Text] [Related]
7. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system.
Taupin V; Renno T; Bourbonnière L; Peterson AC; Rodriguez M; Owens T
Eur J Immunol; 1997 Apr; 27(4):905-13. PubMed ID: 9130643
[TBL] [Abstract][Full Text] [Related]
8. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Dittel BN
Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
Selmaj K; Raine CS; Cross AH
Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
[TBL] [Abstract][Full Text] [Related]
11. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
Karpus WJ; Lukacs NW; McRae BL; Strieter RM; Kunkel SL; Miller SD
J Immunol; 1995 Nov; 155(10):5003-10. PubMed ID: 7594507
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology.
Pope JG; Karpus WJ; VanderLugt C; Miller SD
J Immunol; 1996 May; 156(10):4050-8. PubMed ID: 8621948
[TBL] [Abstract][Full Text] [Related]
13. Adoptively transferred experimental autoimmune encephalomyelitis in SJL/J, PL/J, and (SJL/J x PL/J)F1 mice. Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein.
McCarron R; McFarlin DE
J Immunol; 1988 Aug; 141(4):1143-9. PubMed ID: 3260919
[TBL] [Abstract][Full Text] [Related]
14. The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ.
Sobel RA; Blanchette BW; Bhan AK; Colvin RB
J Immunol; 1984 May; 132(5):2393-401. PubMed ID: 6371137
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms.
Waldburger KE; Hastings RC; Schaub RG; Goldman SJ; Leonard JP
Am J Pathol; 1996 Feb; 148(2):375-82. PubMed ID: 8579100
[TBL] [Abstract][Full Text] [Related]
16. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Donhauser T; Toyka KV; Hartung HP
J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
[TBL] [Abstract][Full Text] [Related]
17. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice.
Ding M; Zhang M; Wong JL; Rogers NE; Ignarro LJ; Voskuhl RR
J Immunol; 1998 Mar; 160(6):2560-4. PubMed ID: 9510151
[TBL] [Abstract][Full Text] [Related]
18. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
Batoulis H; Addicks K; Kuerten S
Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
[TBL] [Abstract][Full Text] [Related]
19. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
20. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats.
Huitinga I; Ruuls SR; Jung S; Van Rooijen N; Hartung HP; Dijkstra CD
Clin Exp Immunol; 1995 May; 100(2):344-51. PubMed ID: 7743675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
